{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:20:34Z","timestamp":1791976834376,"version":"4.4.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,9,21]],"date-time":"2015-09-21T00:00:00Z","timestamp":1442793600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1038\/nm.3951","type":"journal-article","created":{"date-parts":[[2015,9,21]],"date-time":"2015-09-21T16:21:04Z","timestamp":1442852464000},"page":"1154-1162","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":497,"title":["Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits"],"prefix":"10.1038","volume":"21","author":[{"given":"Sang-Won","family":"Min","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara E","family":"Tracy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yungui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Shirakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Sakura","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin","family":"Defensor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue Ann","family":"Mok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Dongmin","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Ellerby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford W","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevan","family":"Krogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Shamloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Gestwicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliezer","family":"Masliah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Verdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,21]]},"reference":[{"key":"BFnm3951_CR1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1468-1331.2008.02513.x","volume":"16","author":"AC Ludolph","year":"2009","unstructured":"Ludolph, A.C. et al. Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur. J. Neurol. 16, 297\u2013309 (2009).","journal-title":"Eur. J. Neurol."},{"key":"BFnm3951_CR2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-007-0237-2","volume":"114","author":"NJ Cairns","year":"2007","unstructured":"Cairns, N.J. et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 114, 5\u201322 (2007).","journal-title":"Acta Neuropathol."},{"key":"BFnm3951_CR3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239\u2013259 (1991).","journal-title":"Acta Neuropathol."},{"key":"BFnm3951_CR4","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1096\/fj.11-199851","volume":"26","author":"CA Lasagna-Reeves","year":"2012","unstructured":"Lasagna-Reeves, C.A. et al. Identification of oligomers at early stages of tau aggregation in Alzheimer's disease. FASEB J. 26, 1946\u20131959 (2012).","journal-title":"FASEB J."},{"key":"BFnm3951_CR5","first-page":"102","volume":"4","author":"Y Ren","year":"2013","unstructured":"Ren, Y. & Sahara, N. Characteristics of tau oligomers. Frontiers Neurol. 4, 102 (2013).","journal-title":"Frontiers Neurol."},{"key":"BFnm3951_CR6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.neures.2005.11.009","volume":"54","author":"S Maeda","year":"2006","unstructured":"Maeda, S. et al. Increased levels of granular tau oligomers: an early sign of brain aging and Alzheimer\u2032s disease. Neurosci. Res. 54, 197\u2013201 (2006).","journal-title":"Neurosci. Res."},{"key":"BFnm3951_CR7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1326-6-39","volume":"6","author":"CA Lasagna-Reeves","year":"2011","unstructured":"Lasagna-Reeves, C.A. et al. Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice. Mol. Neurodegener. 6, 39 (2011).","journal-title":"Mol. Neurodegener."},{"key":"BFnm3951_CR8","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1523\/JNEUROSCI.0587-07.2007","volume":"27","author":"Z Berger","year":"2007","unstructured":"Berger, Z. et al. Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. J. Neurosci. 27, 3650\u20133662 (2007).","journal-title":"J. Neurosci."},{"key":"BFnm3951_CR9","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.1113694","volume":"309","author":"K Santacruz","year":"2005","unstructured":"Santacruz, K. et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science 309, 476\u2013481 (2005).","journal-title":"Science"},{"key":"BFnm3951_CR10","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s12031-011-9604-5","volume":"45","author":"A Sydow","year":"2011","unstructured":"Sydow, A. et al. Reversibility of Tau-related cognitive defects in a regulatable FTD mouse model. J. Mol. Neurosci. 45, 432\u2013437 (2011).","journal-title":"J. Mol. Neurosci."},{"key":"BFnm3951_CR11","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1042\/BST20120071","volume":"40","author":"Y Wang","year":"2012","unstructured":"Wang, Y. & Mandelkow, E. Degradation of tau protein by autophagy and proteasomal pathways. Biochem. Soc. Trans. 40, 644\u2013652 (2012).","journal-title":"Biochem. Soc. Trans."},{"key":"BFnm3951_CR12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature09299","volume":"467","author":"BH Lee","year":"2010","unstructured":"Lee, B.H. et al. Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature 467, 179\u2013184 (2010).","journal-title":"Nature"},{"key":"BFnm3951_CR13","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.ajpath.2012.06.033","volume":"181","author":"HC Tai","year":"2012","unstructured":"Tai, H.C. et al. The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system. Am. J. Pathol. 181, 1426\u20131435 (2012).","journal-title":"Am. J. Pathol."},{"key":"BFnm3951_CR14","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.neuron.2010.08.044","volume":"67","author":"SW Min","year":"2010","unstructured":"Min, S.W. et al. Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron 67, 953\u2013966 (2010).","journal-title":"Neuron"},{"key":"BFnm3951_CR15","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/ncomms1255","volume":"2","author":"TJ Cohen","year":"2011","unstructured":"Cohen, T.J. et al. The acetylation of tau inhibits its function and promotes pathological tau aggregation. Nat. Commun. 2, 252 (2011).","journal-title":"Nat. Commun."},{"key":"BFnm3951_CR16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2010.10.001","volume":"36","author":"GW Kim","year":"2011","unstructured":"Kim, G.W. & Yang, X.J. Comprehensive lysine acetylomes emerging from bacteria to humans. Trends Biochem. Sci. 36, 211\u2013220 (2011).","journal-title":"Trends Biochem. Sci."},{"key":"BFnm3951_CR17","doi-asserted-by":"crossref","first-page":"a006247","DOI":"10.1101\/cshperspect.a006247","volume":"2","author":"EM Mandelkow","year":"2012","unstructured":"Mandelkow, E.M. & Mandelkow, E. Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb. Perspect. Med. 2, a006247 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"BFnm3951_CR18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/hmg\/ddt402","volume":"23","author":"C Cook","year":"2014","unstructured":"Cook, C. et al. Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance. Hum. Mol. Genet. 23, 104\u2013116 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm3951_CR19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","volume":"53","author":"Y Yoshiyama","year":"2007","unstructured":"Yoshiyama, Y. et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53, 337\u2013351 (2007).","journal-title":"Neuron"},{"key":"BFnm3951_CR20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E","volume":"48","author":"GA Jicha","year":"1997","unstructured":"Jicha, G.A., Bowser, R., Kazam, I.G. & Davies, P. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J. Neurosci. Res. 48, 128\u2013132 (1997).","journal-title":"J. Neurosci. Res."},{"key":"BFnm3951_CR21","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0197-4580(00)00157-3","volume":"21","author":"CL Weaver","year":"2000","unstructured":"Weaver, C.L., Espinoza, M., Kress, Y. & Davies, P. Conformational change as one of the earliest alterations of tau in Alzheimer's disease. Neurobiol. Aging 21, 719\u2013727 (2000).","journal-title":"Neurobiol. Aging"},{"key":"BFnm3951_CR22","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/onc.2014.39","volume":"34","author":"F Yeung","year":"2015","unstructured":"Yeung, F. et al. Regulation of the mitogen-activated protein kinase kinase (MEK)-1 by NAD-dependent deacetylases. Oncogene 34, 798\u2013804 (2015).","journal-title":"Oncogene"},{"key":"BFnm3951_CR23","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1038\/ncomms4479","volume":"5","author":"B Wang","year":"2014","unstructured":"Wang, B. et al. Microtubule acetylation amplifies p38 kinase signalling and anti-inflammatory IL-10 production. Nat. Commun. 5, 3479 (2014).","journal-title":"Nat. Commun."},{"key":"BFnm3951_CR24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1128\/MCB.00956-13","volume":"34","author":"Y Zhao","year":"2014","unstructured":"Zhao, Y. et al. p300-dependent acetylation of activating transcription factor 5 enhances C\/EBP\u03b2 transactivation of C\/EBP\u03b1 during 3T3\u2013L1 differentiation. Mol. Cell. Biol. 34, 315\u2013324 (2014).","journal-title":"Mol. Cell. Biol."},{"key":"BFnm3951_CR25","doi-asserted-by":"crossref","first-page":"e7280","DOI":"10.1371\/journal.pone.0007280","volume":"4","author":"T Jaworski","year":"2009","unstructured":"Jaworski, T. et al. AAV-tau mediates pyramidal neurodegeneration by cell-cycle re-entry without neurofibrillary tangle formation in wild-type mice. PLoS ONE 4, e7280 (2009).","journal-title":"PLoS ONE"},{"key":"BFnm3951_CR26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neuroscience.2012.01.040","volume":"207","author":"L Lecourtier","year":"2012","unstructured":"Lecourtier, L. et al. Intact neurobehavioral development and dramatic impairments of procedural-like memory following neonatal ventral hippocampal lesion in rats. Neuroscience 207, 110\u2013123 (2012).","journal-title":"Neuroscience"},{"key":"BFnm3951_CR27","doi-asserted-by":"crossref","first-page":"e21050","DOI":"10.1371\/journal.pone.0021050","volume":"6","author":"H Takeuchi","year":"2011","unstructured":"Takeuchi, H. et al. P301S mutant human tau transgenic mice manifest early symptoms of human tauopathies with dementia and altered sensorimotor gating. PLoS ONE 6, e21050 (2011).","journal-title":"PLoS ONE"},{"key":"BFnm3951_CR28","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1038\/emboj.2010.235","volume":"29","author":"LH Kasper","year":"2010","unstructured":"Kasper, L.H. et al. CBP\/p300 double null cells reveal effect of coactivator level and diversity on CREB transactivation. EMBO J. 29, 3660\u20133672 (2010).","journal-title":"EMBO J."},{"key":"BFnm3951_CR29","doi-asserted-by":"crossref","first-page":"11363","DOI":"10.1093\/nar\/gku827","volume":"42","author":"LH Kasper","year":"2014","unstructured":"Kasper, L.H., Qu, C., Obenauer, J.C., McGoldrick, D.J. & Brindle, P.K. Genome-wide and single-cell analyses reveal a context dependent relationship between CBP recruitment and gene expression. Nucleic Acids Res. 42, 11363\u201311382 (2014).","journal-title":"Nucleic Acids Res."},{"key":"BFnm3951_CR30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/emboj.2010.318","volume":"30","author":"Q Jin","year":"2011","unstructured":"Jin, Q. et al. Distinct roles of GCN5\/PCAF-mediated H3K9ac and CBP\/p300-mediated H3K18\/27ac in nuclear receptor transactivation. EMBO J. 30, 249\u2013262 (2011).","journal-title":"EMBO J."},{"key":"BFnm3951_CR31","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","volume":"128","author":"T Kouzarides","year":"2007","unstructured":"Kouzarides, T. Chromatin modifications and their function. Cell 128, 693\u2013705 (2007).","journal-title":"Cell"},{"key":"BFnm3951_CR32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3233\/JAD-2010-100681","volume":"22","author":"Y Yoshiyama","year":"2010","unstructured":"Yoshiyama, Y., Kojima, A., Ishikawa, C. & Arai, K. Anti-inflammatory action of donepezil ameliorates tau pathology, synaptic loss, and neurodegeneration in a tauopathy mouse model. J. Alzheimers Dis. 22, 295\u2013306 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"BFnm3951_CR33","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/brb3.41","volume":"2","author":"M Faizi","year":"2012","unstructured":"Faizi, M. et al. Thy1-hAPPLond\/Swe+ mouse model of Alzheimer's disease displays broad behavioral deficits in sensorimotor, cognitive and social function. Brain Behav. 2, 142\u2013154 (2012).","journal-title":"Brain Behav."},{"key":"BFnm3951_CR34","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00401-013-1080-2","volume":"125","author":"LT Grinberg","year":"2013","unstructured":"Grinberg, L.T. et al. Argyrophilic grain disease differs from other tauopathies by lacking tau acetylation. Acta Neuropathol. 125, 581\u2013593 (2013).","journal-title":"Acta Neuropathol."},{"key":"BFnm3951_CR35","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ajpath.2013.04.025","volume":"183","author":"DJ Irwin","year":"2013","unstructured":"Irwin, D.J. et al. Acetylated tau neuropathology in sporadic and hereditary tauopathies. Am. J. Pathol. 183, 344\u2013351 (2013).","journal-title":"Am. J. Pathol."},{"key":"BFnm3951_CR36","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/brain\/aws013","volume":"135","author":"DJ Irwin","year":"2012","unstructured":"Irwin, D.J. et al. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies. Brain 135, 807\u2013818 (2012).","journal-title":"Brain"},{"key":"BFnm3951_CR37","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/nn.4067","volume":"18","author":"M Morris","year":"2015","unstructured":"Morris, M. et al. Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice. Nat. Neurosci. 18, 1183\u20131189 (2015).","journal-title":"Nat. Neurosci."},{"key":"BFnm3951_CR38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","volume":"69","author":"WL Smith","year":"2000","unstructured":"Smith, W.L., DeWitt, D.L. & Garavito, R.M. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69, 145\u2013182 (2000).","journal-title":"Annu. Rev. Biochem."},{"key":"BFnm3951_CR39","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMoa010178","volume":"345","author":"BA in t' Veld","year":"2001","unstructured":"in t' Veld, B.A. et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N. Engl. J. Med. 345, 1515\u20131521 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnm3951_CR40","doi-asserted-by":"crossref","first-page":"e0120352","DOI":"10.1371\/journal.pone.0120352","volume":"10","author":"S Aubry","year":"2015","unstructured":"Aubry, S. et al. Assembly and interrogation of Alzheimer's disease genetic networks reveal novel regulators of progression. PLoS ONE 10, e0120352 (2015).","journal-title":"PLoS ONE"},{"key":"BFnm3951_CR41","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1126\/science.1215327","volume":"336","author":"SA Hawley","year":"2012","unstructured":"Hawley, S.A. et al. The ancient drug salicylate directly activates AMP-activated protein kinase. Science 336, 918\u2013922 (2012).","journal-title":"Science"},{"key":"BFnm3951_CR42","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1161\/ATVBAHA.111.237453","volume":"31","author":"Y Zhang","year":"2011","unstructured":"Zhang, Y., Qiu, J., Wang, X., Zhang, Y. & Xia, M. AMP-activated protein kinase suppresses endothelial cell inflammation through phosphorylation of transcriptional coactivator p300. Arterioscler. Thromb. Vasc. Biol. 31, 2897\u20132908 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnm3951_CR43","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/jcp.22824","volume":"227","author":"JY Lim","year":"2012","unstructured":"Lim, J.Y., Oh, M.A., Kim, W.H., Sohn, H.Y. & Park, S.I. AMP-activated protein kinase inhibits TGF-\u03b2-induced fibrogenic responses of hepatic stellate cells by targeting transcriptional coactivator p300. J. Cell. Physiol. 227, 1081\u20131089 (2012).","journal-title":"J. Cell. Physiol."},{"key":"BFnm3951_CR44","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/0470862637.ch15","volume":"259","author":"WC Greene","year":"2004","unstructured":"Greene, W.C. & Chen, L.F. Regulation of NF-\u03baB action by reversible acetylation. Novartis Found. Symp. 259, 208\u2013217 discussion 218\u2013225 (2004).","journal-title":"Novartis Found. Symp."},{"key":"BFnm3951_CR45","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jneuroim.2004.07.008","volume":"156","author":"H Lee","year":"2004","unstructured":"Lee, H. et al. Ethanol selectively modulates inflammatory activation signaling of brain microglia. J. Neuroimmunol. 156, 88\u201395 (2004).","journal-title":"J. Neuroimmunol."},{"key":"BFnm3951_CR46","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/archneur.63.5.693","volume":"63","author":"LG Apostolova","year":"2006","unstructured":"Apostolova, L.G. et al. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch. Neurol. 63, 693\u2013699 (2006).","journal-title":"Arch. Neurol."},{"key":"BFnm3951_CR47","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1212\/WNL.0b013e3181f736a1","volume":"75","author":"GA Kerchner","year":"2010","unstructured":"Kerchner, G.A. et al. Hippocampal CA1 apical neuropil atrophy in mild Alzheimer disease visualized with 7-T MRI. Neurology 75, 1381\u20131387 (2010).","journal-title":"Neurology"},{"key":"BFnm3951_CR48","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1212\/WNL.0b013e318281ccd3","volume":"80","author":"KK Leung","year":"2013","unstructured":"Leung, K.K. et al. Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration. Neurology 80, 648\u2013654 (2013).","journal-title":"Neurology"},{"key":"BFnm3951_CR49","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw, S., Nihal, M. & Ahmad, N. Dose translation from animal to human studies revisited. FASEB J. 22, 659\u2013661 (2008).","journal-title":"FASEB J."},{"key":"BFnm3951_CR50","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1074\/mcp.M112.017707","volume":"11","author":"B Schilling","year":"2012","unstructured":"Schilling, B. et al. Platform-independent and label-free quantitation of proteomic data using MS1 extracted ion chromatograms in skyline: application to protein acetylation and phosphorylation. Mol. Cell. Proteomics 11, 202\u2013214 (2012).","journal-title":"Mol. Cell. Proteomics"},{"key":"BFnm3951_CR51","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1074\/mcp.T600050-MCP200","volume":"6","author":"IV Shilov","year":"2007","unstructured":"Shilov, I.V. et al. The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol. Cell. Proteomics 6, 1638\u20131655 (2007).","journal-title":"Mol. Cell. Proteomics"},{"key":"BFnm3951_CR52","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1002\/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2","volume":"20","author":"DN Perkins","year":"1999","unstructured":"Perkins, D.N., Pappin, D.J., Creasy, D.M. & Cottrell, J.S. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20, 3551\u20133567 (1999).","journal-title":"Electrophoresis"},{"key":"BFnm3951_CR53","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1371\/journal.pbio.0030041","volume":"3","author":"S Pagans","year":"2005","unstructured":"Pagans, S. et al. SIRT1 regulates HIV transcription via Tat deacetylation. PLoS Biol. 3, e41 (2005).","journal-title":"PLoS Biol."},{"key":"BFnm3951_CR54","doi-asserted-by":"crossref","first-page":"40364","DOI":"10.1074\/jbc.M509329200","volume":"280","author":"J Chen","year":"2005","unstructured":"Chen, J. et al. SIRT1 Protects against microglia-dependent amyloid-\u03b2 toxicity through inhibiting NF-\u03baB signaling. J. Biol. Chem. 280, 40364\u201340374 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnm3951_CR55","doi-asserted-by":"crossref","first-page":"11714","DOI":"10.1021\/bi000850r","volume":"39","author":"S Barghorn","year":"2000","unstructured":"Barghorn, S. et al. Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias. Biochemistry 39, 11714\u201311721 (2000).","journal-title":"Biochemistry"},{"key":"BFnm3951_CR56","doi-asserted-by":"crossref","first-page":"10876","DOI":"10.1021\/bi2014745","volume":"50","author":"CL Moore","year":"2011","unstructured":"Moore, C.L. et al. Secondary nucleating sequences affect kinetics and thermodynamics of tau aggregation. Biochemistry 50, 10876\u201310886 (2011).","journal-title":"Biochemistry"},{"key":"BFnm3951_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1073\/pnas.18.1.1","volume":"18","author":"CP Winsor","year":"1932","unstructured":"Winsor, C.P. The Gompertz curve as a growth curve. Proc. Natl. Acad. Sci. USA 18, 1\u20138 (1932).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3951_CR58","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/002215540205000403","volume":"50","author":"A Sun","year":"2002","unstructured":"Sun, A., Nguyen, X.V. & Bing, G. Comparative analysis of an improved thioflavin-s stain, Gallyas silver stain, and immunohistochemistry for neurofibrillary tangle demonstration on the same sections. J. Histochem. Cytochem. 50, 463\u2013472 (2002).","journal-title":"J. Histochem. Cytochem."},{"key":"BFnm3951_CR59","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1124\/mol.110.067520","volume":"79","author":"SW Kim","year":"2011","unstructured":"Kim, S.W. et al. Robust protective effects of a novel multimodal neuroprotectant oxopropanoyloxy benzoic acid (a salicylic acid\/pyruvate ester) in the postischemic brain. Mol. Pharmacol. 79, 220\u2013228 (2011).","journal-title":"Mol. Pharmacol."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.3951.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.3951","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.3951.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T07:47:37Z","timestamp":1718092057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.3951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,21]]},"references-count":59,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["BFnm3951"],"URL":"https:\/\/doi.org\/10.1038\/nm.3951","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,21]]},"assertion":[{"value":"1 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}